Literature DB >> 20865027

Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice.

Sarina A van der Zee1, Jonathan L Halperin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20865027     DOI： 10.1038/nrcardio.2010.126

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  6 in total

1.  Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

Authors:  Robert S Epstein; Thomas P Moyer; Ronald E Aubert; Dennis J O Kane; Fang Xia; Robert R Verbrugge; Brian F Gage; J Russell Teagarden
Journal:  J Am Coll Cardiol       Date:  2010-04-08       Impact factor: 24.094

2.  A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data.

Authors:  Michael A Hillman; Russell A Wilke; Steven H Yale; Humberto J Vidaillet; Michael D Caldwell; Ingrid Glurich; Richard L Berg; John Schmelzer; James K Burmester
Journal:  Clin Med Res       Date:  2005-08

3.  Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.

Authors:  Jeffrey L Anderson; Benjamin D Horne; Scott M Stevens; Amanda S Grove; Stephanie Barton; Zachery P Nicholas; Samera F S Kahn; Heidi T May; Kent M Samuelson; Joseph B Muhlestein; John F Carlquist
Journal:  Circulation       Date:  2007-11-07       Impact factor: 29.690

4.  Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Authors:  Vincent J Willey; Michael F Bullano; Ole Hauch; Matthew Reynolds; Gail Wygant; Lauren Hoffman; George Mayzell; Alex C Spyropoulos
Journal:  Clin Ther       Date:  2004-07       Impact factor: 3.393

5.  CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

Authors:  Y Caraco; S Blotnick; M Muszkat
Journal:  Clin Pharmacol Ther       Date:  2007-09-12       Impact factor: 6.875

6.  Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.

Authors:  Mark H Eckman; Jonathan Rosand; Steven M Greenberg; Brian F Gage
Journal:  Ann Intern Med       Date:  2009-01-20       Impact factor: 25.391
  6 in total
  1 in total

1.  PharmaKU: A Web-Based Tool Aimed at Improving Outreach and Clinical Utility of Pharmacogenomics.

Authors:  Sumi Elsa John; Arshad Mohamed Channanath; Prashantha Hebbar; Rasheeba Nizam; Thangavel Alphonse Thanaraj; Fahd Al-Mulla
Journal:  J Pers Med       Date:  2021-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.